文献速递胸部肿瘤放疗放疗物理与技术

局部晚期非小细胞肺癌光子与质子放疗中心包积液及死亡相关胸部剂量模式研究

Probing thoracic dose patterns associated to pericardial effusion and mortality in patients treated with photons and protons for locally advanced non-small-cell lung cancer.
PubMed 文献 · Radiother Oncol · 2021-05-09

该研究纳入178例接受调强放疗或被动散射质子治疗的局部晚期非小细胞肺癌患者,43.5%发生≥2级心包积液。多变量Cox分析显示放疗技术未影响心包积液发生或总生存,体素分析发现心与肺中与心包积液终点显著相关的剂量模式,但未发现与死亡相关的剂量模式。

要点

  • 43.5%患者发生≥2级心包积液,但其发生与总生存无关(p=0.34)。
  • 尽管质子治疗剂量学优势显著,放疗技术未影响心包积液或总生存。
  • 体素分析显示心与肺中与心包积液相关剂量模式,未发现死亡相关模式。

核心结论

  • 空间分辨分析揭示了与放射性心脏毒性相关的剂量模式,以及质子治疗与调强放疗中观察到的器官水平剂量-反应不匹配。
  • 质子治疗 spared 的胸部区域与心包积液发展涉及区域重叠不佳。
  • PICA和连接图是评估体素分析推断稳健性的有价值工具。

研究设计与样本

  • 研究纳入178例接受调强放疗或被动散射质子治疗的局部晚期非小细胞肺癌患者。
  • 通过多变量Cox比例风险模型识别与心包积液或总生存相关的临床和剂量学因素。
  • 对有无心包积液及死亡患者间的局部剂量差异进行体素分析,并用基于概率独立成分分析和连接图的空间特性表征评估稳健性。

主要发现

  • 43.5%患者发生≥2级心包积液。
  • 多变量分析选择了几项非剂量学变量用于所考虑的结局,而时间依赖性心包积液发生与总生存无关(p=0.34)。
  • 尽管被动散射质子治疗剂量学优势显著,放疗技术未影响心包积液发生或总生存。
  • 体素分析突出显示心与肺中与心包积液终点显著相关的大面积重叠簇。
  • 未发现与死亡终点相关的显著剂量模式;PICA识别出43个均匀散布于胸部的成分,连接图显示主要心肺亚结构间剂量 modest 相关。

关键数值与推荐

  • 心包积液终点为≥2级心包积液。
  • 时间依赖性心包积液发生与总生存的多变量Cox分析p=0.34。
  • PICA识别出43个成分。

临床怎么用

  • 对于局部晚期非小细胞肺癌放疗,应关注心与肺中与心包积液相关的剂量模式,即使采用质子治疗也需评估心脏毒性风险。
  • 质子治疗剂量学优势未转化为心包积液或生存获益,提示需结合空间剂量模式优化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To investigate thoracic dose-response patterns for pericardial effusion (PCE) and mortality in patients treated for locally advanced Non-Small-Cell Lung Cancer (NSCLC) by Intensity Modulated RT (IMRT) or Passive-Scattering Proton Therapy (PSPT). METHODS: Among 178 patients, 43.5% developed grade ≥ 2 PCE. Clinical and dosimetric factors associated with PCE or overall survival (OS) were identified via multi-variable Cox proportional hazards modeling. The Voxel-Based Analyses (VBAs) of local dose differences between patients with and without PCE and mortality was performed. The robustness of VBA results was assessed by a novel characterization of spatial properties of dose distributions based on probabilistic independent component analysis (PICA) and connectograms. RESULTS: Several non-dosimetric variables were selected by the multivariable analysis for the considered outcomes, while the time-dependent PCE onset was uncorrelated with the OS (p = 0.34) at a multi-variable Cox analysis. Despite the significant PSPT dosimetric advantage, the RT technique did not affect the occurrence of PCE or OS. VBAs highlighted largely overlapping clusters significantly associated with PCE endpoints in heart and lungs. No significant dosimetric patterns related to mortality endpoints were found. PICA identified 43 components homogeneously scattered within thorax, while connectograms showed modest correlations between doses in main cardio-pulmonary substructures. CONCLUSIONS: Spatially resolved analysis highlighted dose patterns related to radiation-induced cardiac toxiciy and the observed organ-based dose-response mismatch in PSPT and IMRT. Indeed, the thoracic regions spared by PSPT poorly overlapped with the areas involved in PCE development, as highlited by VBA. PICA and connectograms proved valuable tools for assessing the robusteness of obtained VBA inferences.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Cella L, Monti S, Xu T, et al. Probing thoracic dose patterns associated to pericardial effusion and mortality in patients treated with photons and protons for locally advanced non-small-cell lung cancer. Radiother Oncol. 2021. PMID: 33979653. doi:10.1016/j.radonc.2021.04.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。